Quick Summary:
In an ever-evolving healthcare landscape, the significance of accurate and efficient diagnosis stands paramount. With this, the increasingly prevalent global issue of dengue becomes unignorable. The dengue testing market offers an array of precise, reliable, and innovative diagnostic solutions including ELISA, RT-PCR, and rapid dengue IgG/IgM tests. Not only are these tools vital in clinical care, but they are also central to disease control, academic research, vaccine development, and surveillance activities.
The dengue testing market is growing at an increasing rate, influenced by factors such as worldwide urbanization, advancements in technology and a rise in public awareness campaigns organized by global governments. These test kits and diagnostic solutions, utilized by hospitals and diagnostic centers around the globe, are paramount for the early detection of severe cases and the confirmation and differential diagnosis with other infectious diseases. In addition, major players in the market are investing in research and development, striving to provide cost-effective and efficient dengue testing kits.
The global dengue testing market size reached US$ 555.5 Million in 2022. Looking forward, the publisher expects the market to reach US$ 761.6 Million by 2028, exhibiting a growth rate (CAGR) of 5.2% during 2023-2028.
Dengue, also known as breakbone fever, is a viral infection that spreads through the bite of an infected Aedes aegypti mosquito. It causes ache in the joints and muscles, high fever, abdominal pain, vomiting, difficulty in breathing, clammy and cold skin, headache, pain behind the eyes, fatigue, rashes, and mild bleeding in the nose and gums. It is diagnosed via dengue testing, which includes enzyme-linked immunosorbent assay (ELISA), RT-PCR, and dengue IgG/IgM rapid tests. Dengue testing is performed by medical professionals using a blood sample to identify the different serotypes of the dengue virus.
2. What is the expected growth rate of the global dengue testing market during 2023-2028?
3. What are the key factors driving the global dengue testing market?
4. What has been the impact of COVID-19 on the global dengue testing market?
5. What is the breakup of the global dengue testing market based on the test type?
6. What is the breakup of the global dengue testing market based on the end user?
7. What are the key regions in the global dengue testing market?
8. Who are the key players/companies in the global dengue testing market?
Dengue, also known as breakbone fever, is a viral infection that spreads through the bite of an infected Aedes aegypti mosquito. It causes ache in the joints and muscles, high fever, abdominal pain, vomiting, difficulty in breathing, clammy and cold skin, headache, pain behind the eyes, fatigue, rashes, and mild bleeding in the nose and gums. It is diagnosed via dengue testing, which includes enzyme-linked immunosorbent assay (ELISA), RT-PCR, and dengue IgG/IgM rapid tests. Dengue testing is performed by medical professionals using a blood sample to identify the different serotypes of the dengue virus.
Dengue Testing Market Trends:
The growing cases of dengue on account of the rising global warming and breeding sites of mosquitos across the globe represents one of the major factors driving the market. Moreover, accurate and efficient diagnosis of dengue plays a pivotal role in clinical care. It assists in pathogenesis, clinical trials, outbreak control, academic research, vaccine development, surveillance activities, early detection of severe cases, and case confirmation and differential diagnosis with other infectious diseases. These benefits are positively influencing the demand for dengue testing around the world. Besides this, densely populated areas worldwide are more disease-prone due to low living conditions. This, along with poor sanitation and waste management techniques due to lack of public awareness, is stimulating the growth of the market. In addition, healthcare professionals are encouraging people to prevent dengue by self-protection and thermal fogging of insecticides. This, coupled with awareness campaigns organized by the government of several countries, is propelling the growth of the market. Other growth-inducing factors are rapid urbanization and technological advancements in the healthcare industry. Furthermore, key market players are extensively investing in research and development (R&D) activities to develop highly efficient and cost-effective dengue test kits.Key Market Segmentation:
The publisher provides an analysis of the key trends in each sub-segment of the global dengue testing market report, along with forecasts at the global, regional and country level from 2023-2028. The report has categorized the market based on test type and end user.Breakup by Test Type:
- ELISA-based Tests
- RT-PCR based Tests
- Dengue IgG/IgM Rapid Test
- Others
Breakup by End User:
- Hospitals
- Diagnostic Centers
- Others
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Abnova Corporation, CerTest Biotec S.L., DiaSorin S.p.A., F. Hoffmann-La Roche AG, InBios International Inc., NovaTec Immundiagnostica GmbH, OriGene Technologies Inc., PerkinElmer Inc., Quest Diagnostics Incorporated and Thermo Fisher Scientific Inc.Key Questions Answered in This Report
1. How big is the global dengue testing market?2. What is the expected growth rate of the global dengue testing market during 2023-2028?
3. What are the key factors driving the global dengue testing market?
4. What has been the impact of COVID-19 on the global dengue testing market?
5. What is the breakup of the global dengue testing market based on the test type?
6. What is the breakup of the global dengue testing market based on the end user?
7. What are the key regions in the global dengue testing market?
8. Who are the key players/companies in the global dengue testing market?
Frequently Asked Questions about the Global Dengue Testing Market
What is the estimated value of the Global Dengue Testing Market?
What is the growth rate of the Global Dengue Testing Market?
What is the forecasted size of the Global Dengue Testing Market?
Who are the key companies in the Global Dengue Testing Market?
| Report Attribute | Details |
|---|---|
| No. of Pages | 146 |
| Published | September 2023 |
| Forecast Period | 2022 - 2028 |
| Estimated Market Value ( USD | $ 555.5 Million |
| Forecasted Market Value ( USD | $ 761.6 Million |
| Compound Annual Growth Rate | 5.4% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
Table of Contents
1 Preface3 Executive Summary10 Value Chain Analysis12 Price Analysis
2 Scope and Methodology
4 Introduction
5 Global Dengue Testing Market
6 Market Breakup by Test Type
7 Market Breakup by End User
8 Market Breakup by Region
9 SWOT Analysis
11 Porters Five Forces Analysis
13 Competitive Landscape
List of Tables
List of Tables
Companies Mentioned
- Abbott Laboratories
- Abnova Corporation
- CerTest Biotec S.L.
- DiaSorin S.p.A.
- F. Hoffmann-La Roche AG
- InBios International Inc.
- NovaTec Immundiagnostica GmbH
- OriGene Technologies Inc.
- PerkinElmer Inc.
- Quest Diagnostics Incorporat
Methodology
LOADING...
